1. Effect of L-arginine or L-citrulline oral supplementation on blood pressure and right ventricular function in heart failure patients with preserved ejection fraction.
Juan José Orozco-Gutiérrez1, Lilia Castillo-Martínez1, 2, Arturo Orea-Tejeda1, 2, Oscar Vázquez-Díaz1, Adrián Valdespino-Trejo1, René Narváez-David2, Candace Keirns-Davis3, Olín Carrasco-Ortiz1, Adolfo Navarro-Navarro1, Rocío Sánchez-Santillán1.Cardiol J 2010; 17, 6: 612–618)
2. Effects of oral L-arginine supplementation on exercise-induced QT dispersion and exercise tolerance in stable angina pectoris
Bronislaw Bednarz, Robert Wolk, Tomasz Chamiec, Krystyna Herbaczynska-Cedro, Dariusz Winek, Leszek Ceremuzynski. International Journal of Cardiology 75 (2000) 205 –210
3. Long-term L-Arginine Supplementation Improves Small-Vessel Coronary Endothelial Function in Humans
Amir Lerman, John C. Burnett, Jr, Stuart T. Higano, Linda J. McKinley and David R. Holmes, Jr; Circulation. 1998;97:2123-2128
4. L-Arginine Improves Post-Ischemic Vasodilation in Coronary Heart Disease Patients Taking Vasodilating Drugs
Arcangelo lannuzzi, Gabriella Jannuzzo, Cecilia Sapio, Paolo Pauciullo, Domenico Jorio, Nicola Spampinato, Mario Mancini, and Paolo Rubba, MD; J Cardiovasc Pharmacol Therapeut 6 (2): 121-127, 2001
5. Oral administration of L-arginine in patients with angina or following myocardial infarction may be protective by increasing plasma superoxide dismutase and total thiols with reduction in serum cholesterol and xanthine oxidase
Pratima Tripathi, M. Chandra and M.K. Misra, Oxidative Medicine and Cellular Longevity 2:4, 231-237.
6. Resveratrol Improves Vascular Function in Patients With Hypertension and Dyslipidemia by Modulating NO Metabolism
Albino Carrizzo, Annibale Puca, Antonio Damato, Marina Marino, Elio Franco, Franco Pompeo, Anna Traficante, Fabio Civitillo, Luigi Santini, Valentina Trimarco, Carmine Vecchione Hypertension. 2013; 62:359-366.
7. One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease
Tomé-Carneiro J, Gonzálvez M, Larrosa M, Yáñez-Gascón MJ, García-Almagro FJ, Ruiz-Ros JA, García-Conesa MT, Espín JC, Tomás-Barberán FA, The American Journal of Cardiology, 2012 Aug 1;110 (3): 356-63
8. Short-term effects of L-citrulline supplementation on arterial stiffness in middle-aged men
Masayuki Ochiai , Toshio Hayashi, Masahiko Morita, Koichiro In, Morihiko Maeda , Fumiko Watanabe , Koji Morishita; International Journal of Cardiology 155 (2012) 257–261
9. Improvement of ventricular function in systolic heart failure patients with oral L-citrulline supplementation
Karla Balderas-Munoz, Lilia Castillo-Martinez, Arturo Orea-Tejeda, Oscar Infante-Vazquez, Marcelo Utrera-Lagunas, Raul Martinez-Memije, Candace Keirns-Davis, Bryan Becerra-Luna, Gabriela Sanchez-Vidal; Cardiol J 2012; 19, 6: 612–617
10. Effects of Pomegranate Juice Consumption on Myocardial Perfusion in Patients With Coronary Heart Disease
Michael D. Sumner, Melanie Elliott-Eller, RN, MSN, Gerdi Weidner, Jennifer J. Daubenmier, Mailine H. Chew, Ruth Marlin, Caren J. Raisin, RN, and Dean Ornish, Am J Cardiol 2005;96: 810–814
11. Pycnogenol®, French Maritime Pine Bark Extract, Augments Endothelium-Dependent Vasodilation in Humans
Kenji Nishioka, Takayuki Hidaka, Shuji Nakamura, Takashi Umemumura, Daisuke Jitsuiki, Junko Soga, Chikara Goto, Kazuaki Chayama, Masao Yoshizumi, and Yukihito Higashi; Hypertens Res 2007;30: 775–780
12. Effects of Treatment With the Antioxidant a-Lipoic Acid on Cardiac Autonomic Neuropathy in NIDDM Patients
Dan Ziegler, MD; Helmut Schatz, MD; Frank Conrad; F. Arnold Gries, MD; Heinz Ulrich, MD; The Dekan Study Group; Gerhard Reichel, MD; Diabetes Care, Volume 20, No 3, Mar 1997
13. Therapeutic Effect of Taurine in Congestive Heart Failure: A Double-Blind Crossover Trial
J Azuma, A Sawamura, N Awata, H Ohta, T Hamaguchi, H Harada, K Takihara,H Hasegawa, T Yamagami, T Ishiyama; Clin. Cardiol. 8, 276-282 (1985)
14. Usefulness of taurine in chronic congestive heart failure and its prospective application.
Azuma J, Sawamura A, Awata N;Japanese Circulation Journal [1992, 56 (1):95-99].
15. Fifteen Year Mortality in Coronary Drug Project Patients: Long-Term Benefit With Niacin
Canner PL, Berge KG, Wenger NK, Stamler J, Friedman L, Prineas RJ, Friedewald W.; J Am Coli CardioI1986; 8:1245-55
16. Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease
Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ..N Engl J Med 2001; 345:1583-1592
17. Benefits of Niacin in Patients With Versus Without the Metabolic Syndrome and Healed Myocardial Infarction (from the Coronary Drug Project)
Paul L. Canner, Curt D. Furberg, and Mark E. McGovern, MD ; Am J Cardiol 2006;97:477– 479
18. Serum Zinc Level and Coronary Heart Disease Events in Patients With Type 2 Diabetes
Soinio M, Marniemi J, Laakso M, Pyörälä K, Lehto S, Rönnemaa T. Diabetes Care. 2007 Mar; 30 (3): 523-528.
19. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS).
Nigel G Stephens, Ann Parsons, Peter M Schofield, Frank Kelly, Kevin Cheeseman, Malcolm J Mitchinson, Morris J Brown;Lancet 1996; 347: 781-86
20. Vitamin E and Coronary Heart Disease in Tunisians
Moncef Feki, Malek Souissi, Elyes Mokhtar, Mohamed Hsairi, Naziha Kaabachi, Helena Antebi, Louis Ge´rald Alcindor, Rachid Mechmeche, and Abderraouf Mebazaa; Clinical Chemistry 46:9 1401–1405 (2000)
21. Vitamin E consumption and the risk of coronary heart disease in men.
Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC.N Engl J Med. 1993 May 20; 328 (20):1450-6.
22. The Effects of Vitamin D Supplementation on Physical Function and Quality of Life in Older Patients With Heart Failure A Randomized Controlled Trial
Witham, Crighton LJ, Gillespie ND, Struthers AD, McMurdo ME.; Circ Heart Fail. 2010;3:195-201;